Spots Global Cancer Trial Database for invasive breast carcinoma

Every month we try and update this database with for invasive breast carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer	NCT02453620	Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Invasive Breast... Malignant Solid...	Biopsy Blood Sample Bone Scan Computed Tomogr... Entinostat Ipilimumab Nivolumab Pharmacogenomic... Pharmacological... Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer	NCT01266642	Ductal Breast C... Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	External Beam R... External Beam R... Hypofractionate... Laboratory Biom... Quality-of-Life... Questionnaire A... Whole Breast Ir... Whole Breast Ir...	40 Years -	M.D. Anderson Cancer Center
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer	NCT00477100	Inflammatory Br... Invasive Breast... Second Primary ...	Biospecimen Col... Interview Medical Chart R... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery	NCT04169542	Breast Ductal C... COVID-19 Infect... Hereditary Brea... Invasive Breast...	Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery	NCT03188393	Invasive Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Biopsy of Breas...	18 Years -	NRG Oncology
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer	NCT02453620	Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Invasive Breast... Malignant Solid...	Biopsy Blood Sample Bone Scan Computed Tomogr... Entinostat Ipilimumab Nivolumab Pharmacogenomic... Pharmacological... Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery	NCT03188393	Invasive Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Biopsy of Breas...	18 Years -	NRG Oncology
Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors	NCT02856503	Breast Cancer Invasive Breast... Ductal Carcinom...	Vitamin D3	18 Years -	University of Miami
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer	NCT00601900	Invasive Breast... Recurrent Breas... Stage III Breas... Stage IV Breast...	Bevacizumab Laboratory Biom... Letrozole Questionnaire A... Tamoxifen Citra...	18 Years -	National Cancer Institute (NCI)
Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion	NCT05036083	Breast Carcinom... Invasive Breast...	Contrast-Enhanc... Digital Tomosyn... Electronic Heal... Iodinated Contr...	18 Years -	M.D. Anderson Cancer Center
Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer	NCT04087057	Invasive Breast...	Interview Medical Chart R... Questionnaire	18 Years -	M.D. Anderson Cancer Center
Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer	NCT04001829	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Docetaxel Paclitaxel Quality-of-Life... Questionnaire A...	18 Years -	Eastern Cooperative Oncology Group
The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer	NCT03454529	Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Laboratory Biom... Simvastatin	19 Years -	Barbara Ann Karmanos Cancer Institute
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy	NCT04379570	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... HER2 Negative B... Hormone Recepto... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Educational Int... Text Message-ba... Motivational In... Best Practice Questionnaire A... Quality-of-Life...	18 Years -	Alliance for Clinical Trials in Oncology
Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer	NCT03323658	Breast Atypical... Breast Atypical... Breast Ductal C... Breast Lobular ... Invasive Breast...	Bexarotene Questionnaire A...	18 Years -	National Cancer Institute (NCI)
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer	NCT03345420	Ductal Breast C... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Hypofractionate...	18 Years -	University of Utah
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial	NCT05710328	Anatomic Stage ... Anatomic Stage ... HER2-Positive B... Invasive Breast...	Chemotherapy Computed Tomogr... Fludeoxyglucose... Positron Emissi... Surgical Proced...	18 Years -	Eastern Cooperative Oncology Group
Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer	NCT02883062	Invasive Breast... Stage II Breast... Stage III Breas... Triple-Negative...	Atezolizumab Biospecimen Col... Carboplatin Lumpectomy Mastectomy Paclitaxel	18 Years -	National Cancer Institute (NCI)
Testing the Addition of an Individualized Vaccine to Nab-Paclitaxel, Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer	NCT03606967	Anatomic Stage ... Invasive Breast... Metastatic Trip...	Biopsy Biospecimen Col... Carboplatin Computed Tomogr... Durvalumab Gemcitabine Hyd... Magnetic Resona... Nab-paclitaxel Personalized Sy... Poly ICLC Tremelimumab	18 Years -	National Cancer Institute (NCI)
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer	NCT01622868	HER2-Positive B... Invasive Breast... Metastatic Mali... Recurrent Breas... Stage IV Breast...	Laboratory Biom... Lapatinib Ditos... Stereotactic Ra... Whole-Brain Rad...	18 Years -	National Cancer Institute (NCI)
Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer	NCT05177796	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Inflamma... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Triple-Negative...	Carboplatin Cyclophosphamid... Doxorubicin Paclitaxel Panitumumab Pembrolizumab	18 Years -	M.D. Anderson Cancer Center
Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer	NCT04022772	Breast Carcinom... Breast Ductal C... Invasive Breast... Recurrent Breas...	Best Practice Medical Chart R... Quality-of-Life... Questionnaire A... Supportive Care	18 Years -	M.D. Anderson Cancer Center
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast	NCT04009044	Cancer Survivor Ductal Breast C... Invasive Breast...	Afimoxifene Core Biopsy Questionnaire A...	18 Years -	Northwestern University
Capecitabine in Women With Operable Breast Cancer	NCT00148720	Invasive Breast... Primary Invasiv... Stage I Breast ... Stage II Breast... Stage III Breas...	Capecitabine	18 Years -	Dana-Farber Cancer Institute
Intermittent Fasting for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery	NCT05327608	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Ductal C... HER2 Negative B... Hormone Recepto... Invasive Breast...	Short-Term Fast...	18 Years -	Thomas Jefferson University
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy	NCT04379570	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... HER2 Negative B... Hormone Recepto... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Educational Int... Text Message-ba... Motivational In... Best Practice Questionnaire A... Quality-of-Life...	18 Years -	Alliance for Clinical Trials in Oncology
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative	NCT02276443	Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative...	Chemotherapy Immunotherapy Laboratory Biom... Lymph Node Biop... Ultrasonography	18 Years -	M.D. Anderson Cancer Center
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer	NCT02918474	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Ductal Breast C... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Sporadic Breast...	Decision Aid Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer	NCT03345420	Ductal Breast C... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Hypofractionate...	18 Years -	University of Utah
Intermittent Fasting for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery	NCT05327608	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Ductal C... HER2 Negative B... Hormone Recepto... Invasive Breast...	Short-Term Fast...	18 Years -	Thomas Jefferson University
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer	NCT05464810	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... HER2-Negative B... Hormone Recepto... Invasive Breast...	Letrozole Simvastatin	18 Years -	Emory University
Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer	NCT04022772	Breast Carcinom... Breast Ductal C... Invasive Breast... Recurrent Breas...	Best Practice Medical Chart R... Quality-of-Life... Questionnaire A... Supportive Care	18 Years -	M.D. Anderson Cancer Center
Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer	NCT04001829	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Docetaxel Paclitaxel Quality-of-Life... Questionnaire A...	18 Years -	Eastern Cooperative Oncology Group
Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE Trial	NCT04667481	Breast Cancer Invasive Breast...	Aerobic Exercis... Resistance Exer... Exercise Interv... Questionnaire A... Quality-of-Life...	18 Years - 75 Years	University of Washington
Metformin and Nightly Fasting in Women With Early Breast Cancer	NCT05023967	Anatomic Stage ... Anatomic Stage ... Breast Ductal C... Invasive Breast...	Biospecimen Col... Extended Releas... Monitoring Nutritional Ass... Short-Term Fast...	18 Years -	M.D. Anderson Cancer Center
Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses	NCT03185871	Breast Carcinom...	Celecoxib	18 Years - 80 Years	University of Wisconsin, Madison
Testing the Addition of an Individualized Vaccine to Nab-Paclitaxel, Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer	NCT03606967	Anatomic Stage ... Invasive Breast... Metastatic Trip...	Biopsy Biospecimen Col... Carboplatin Computed Tomogr... Durvalumab Gemcitabine Hyd... Magnetic Resona... Nab-paclitaxel Personalized Sy... Poly ICLC Tremelimumab	18 Years -	National Cancer Institute (NCI)
Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer	NCT02883062	Invasive Breast... Stage II Breast... Stage III Breas... Triple-Negative...	Atezolizumab Biospecimen Col... Carboplatin Lumpectomy Mastectomy Paclitaxel	18 Years -	National Cancer Institute (NCI)
Exercise in Improving Health and Quality of Life in Breast Cancer Survivors	NCT03679559	Invasive Breast...	Best Practice Exercise Interv... Exercise Interv... Exercise Interv... Informational I... Laboratory Biom... Monitoring Devi... Quality-of-Life... Questionnaire A...	-	Roswell Park Cancer Institute
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast	NCT04009044	Cancer Survivor Ductal Breast C... Invasive Breast...	Afimoxifene Core Biopsy Questionnaire A...	18 Years -	Northwestern University
Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer	NCT02689427	Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative...	Axillary Lymph ... Enzalutamide Laboratory Biom... Lymph Node Biop... Paclitaxel Therapeutic Con...	18 Years -	M.D. Anderson Cancer Center
Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer	NCT03323658	Breast Atypical... Breast Atypical... Breast Ductal C... Breast Lobular ... Invasive Breast...	Bexarotene Questionnaire A...	18 Years -	National Cancer Institute (NCI)
Broccoli Sprout Extract in Treating Patients With Breast Cancer	NCT01753908	Ductal Breast C... Ductal Breast C... Estrogen Recept... Estrogen Recept... Invasive Breast... Lobular Breast ... Postmenopausal Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas...	Broccoli Sprout... Laboratory Biom... Pharmacological... Placebo	21 Years -	Roswell Park Cancer Institute
Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative	NCT02456857	Invasive Breast... Triple-Negative...	Bevacizumab Everolimus Laboratory Biom... Pegylated Lipos...	18 Years -	M.D. Anderson Cancer Center
Delayed-Delayed Breast Reconstruction	NCT01256528	Breast Cancer	Delayed Breast ...	18 Years -	M.D. Anderson Cancer Center
Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer	NCT04481113	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... HER2 Negative B... Hormone Recepto... Invasive Breast... Multifocal Brea... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Unilateral Brea...	Abemaciclib Niraparib Tosyl...	18 Years -	OHSU Knight Cancer Institute
Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer	NCT00429182	Breast Cancer Metastatic Brea... Invasive Breast...	Carboplatin Cyclophosphamid... Thiotepa Stem Cell Trans...	18 Years - 55 Years	M.D. Anderson Cancer Center
Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer	NCT04022772	Breast Carcinom... Breast Ductal C... Invasive Breast... Recurrent Breas...	Best Practice Medical Chart R... Quality-of-Life... Questionnaire A... Supportive Care	18 Years -	M.D. Anderson Cancer Center
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer	NCT02876640	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Ductal C... Early Stage Bre... Invasive Breast...	Biospecimen Col... Retinoid 9cUAB3... Therapeutic Con...	18 Years -	National Cancer Institute (NCI)
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer	NCT05340673	Breast Ductal C... Invasive Breast...	Agent Affecting... Petrolatum-Mine... Quality-of-Life... Questionnaire A...	18 Years -	City of Hope Medical Center
Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer	NCT02530489	Breast Adenocar... Invasive Breast... Triple-Negative...	Atezolizumab Nab-paclitaxel	18 Years -	M.D. Anderson Cancer Center
A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation	NCT03437161	Breast Cancer	Radiation Thera...	18 Years -	NYU Langone Health
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial	NCT04457596	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... HER2 Positive B... Invasive Breast... Multifocal Brea... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Synchronous Bil...	Trastuzumab Emt... Placebo Adminis... Tucatinib Questionnaire A... Quality-of-Life...	18 Years -	Alliance for Clinical Trials in Oncology
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases	NCT03796273	Anatomic Stage ... Astrocytoma Breast Carcinom... Glioma Invasive Breast... Oligodendroglio... Prognostic Stag... Recurrent Gliom...	Best Practice Ketoconazole	18 Years -	Wake Forest University Health Sciences
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer	NCT02954874	Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage II Breast... Stage III Breas... Triple-Negative...	Biospecimen Col... Laboratory Biom... Patient Observa... Pembrolizumab Quality-of-Life... Questionnaire A... Radiation Thera...	18 Years -	National Cancer Institute (NCI)
Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer	NCT05071677	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Triple-Negative...	Discussion Interview Survey Administ...	18 Years -	M.D. Anderson Cancer Center
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer	NCT03971409	Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Invasive Breast... Recurrent Breas... Triple-Negative... Unresectable Br...	Anti-OX40 Antib... Avelumab Binimetinib Utomilumab Liposomal Doxor... Sacituzumab Gov...	18 Years -	University of California, San Francisco
The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer	NCT03454529	Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Laboratory Biom... Simvastatin	19 Years -	Barbara Ann Karmanos Cancer Institute
Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer	NCT03518242	Breast Cancer F... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Cyclophosphamid... Methotrexate Capecitabine Biospecimen Col...	18 Years -	Fred Hutchinson Cancer Center
BrUOG 291: Five Fraction Partial Breast Irradiation Using Non-invasive Image-guided Breast Brachytherapy (NIBB)	NCT01961531	Breast Cancer	Accuboost APBI	50 Years -	Brown University
Exercise in Improving Health and Quality of Life in Breast Cancer Survivors	NCT03679559	Invasive Breast...	Best Practice Exercise Interv... Exercise Interv... Exercise Interv... Informational I... Laboratory Biom... Monitoring Devi... Quality-of-Life... Questionnaire A...	-	Roswell Park Cancer Institute
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy	NCT04266249	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Docetaxel Lumpectomy Mastectomy Nab-paclitaxel Paclitaxel Pertuzumab Radiation Thera... Trastuzumab Trastuzumab Emt...	18 Years -	Eastern Cooperative Oncology Group
Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer	NCT04294225	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Early-Stage Bre... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Anastrozole Letrozole	18 Years -	Mayo Clinic
Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer	NCT01334021	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Biopsy Conventional Su... Genetic Testing	18 Years -	M.D. Anderson Cancer Center
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer	NCT03414970	Ductal Breast C... Invasive Breast... Lobular Breast ... Medullary Breas... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Tubular Breast ...	Radiation Thera... Questionnaire A... Quality-of-Life... Laboratory Biom... Hypofractionate...	18 Years -	Alliance for Clinical Trials in Oncology
Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer	NCT05177796	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Inflamma... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Triple-Negative...	Carboplatin Cyclophosphamid... Doxorubicin Paclitaxel Panitumumab Pembrolizumab	18 Years -	M.D. Anderson Cancer Center
Metformin and Nightly Fasting in Women With Early Breast Cancer	NCT05023967	Anatomic Stage ... Anatomic Stage ... Breast Ductal C... Invasive Breast...	Biospecimen Col... Extended Releas... Monitoring Nutritional Ass... Short-Term Fast...	18 Years -	M.D. Anderson Cancer Center
A Home-Based Walking Program and rTMS in Helping Breast Cancer Survivors Get More Physical Activity	NCT03789877	Cancer Survivor Invasive Breast...	Physical Activi... Questionnaire A... Repetitive Tran... Sham Interventi...	18 Years - 64 Years	Roswell Park Cancer Institute
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy	NCT04266249	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Docetaxel Lumpectomy Mastectomy Nab-paclitaxel Paclitaxel Pertuzumab Radiation Thera... Trastuzumab Trastuzumab Emt...	18 Years -	Eastern Cooperative Oncology Group
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation	NCT05059444	Bladder Carcino... Ureter Carcinom... Renal Pelvis Ca... Non-small Cell ... Invasive Breast... Cutaneous Melan... Esophageal Carc... Gastroesophagea... Gastric Adenoca... Pancreatic Aden... Squamous Cell C... Epithelial Ovar... Fallopian Tube ... Endometrial Car... Renal Cell Carc...	Guardant Reveal	18 Years -	Guardant Health, Inc.
RBX7455 Before Surgery for the Treatment of Operable Breast Cancer	NCT04139993	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Triple-Negative...	Microbiota-base...	18 Years -	Mayo Clinic
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer	NCT01272037	Breast Ductal C... Invasive Breast... Multicentric Br... Multifocal Brea... Synchronous Bil...	Anastrozole Exemestane Laboratory Biom... Letrozole Quality-of-Life... Systemic Chemot... Tamoxifen Citra...	18 Years -	National Cancer Institute (NCI)
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer	NCT03077841	Ductal Breast C... Early-Stage Bre... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Laboratory Biom... Partial Breast ... Questionnaire A...	50 Years -	M.D. Anderson Cancer Center
A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation	NCT03437161	Breast Cancer	Radiation Thera...	18 Years -	NYU Langone Health
Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses	NCT03185871	Breast Carcinom...	Celecoxib	18 Years - 80 Years	University of Wisconsin, Madison
Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer	NCT04087057	Invasive Breast...	Interview Medical Chart R... Questionnaire	18 Years -	M.D. Anderson Cancer Center
Breast Cancer Index (BCI) Registry	NCT04875351	Breast Cancer	Breast Cancer I...	18 Years -	Biotheranostics, Inc.
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative	NCT02276443	Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative...	Chemotherapy Immunotherapy Laboratory Biom... Lymph Node Biop... Ultrasonography	18 Years -	M.D. Anderson Cancer Center
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer	NCT03077841	Ductal Breast C... Early-Stage Bre... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Laboratory Biom... Partial Breast ... Questionnaire A...	50 Years -	M.D. Anderson Cancer Center
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer	NCT05319873	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Invasive Breast... Locally Advance... Metastatic HER2... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Carboplatin Docetaxel Fulvestrant Pertuzumab Quality-of-Life... Ribociclib Trastuzumab Tucatinib	18 Years -	Jonsson Comprehensive Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: